loading

Dbv Technologies Adr Azioni (DBVT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
94.56%
1.465
0.753 0.511 1.072 1.161
Operating Expenses
55.55%
42.58
27.37 24.37 31.40 35.00
Benefits Costs and Expenses
55.30%
43.22
27.83 23.52 31.51 34.28
Costs And Expenses
55.30%
43.22
27.83 23.52 31.51 34.28
Operating Income/Loss
54.45%
-41.11
-26.62 -23.86 -30.33 -33.84
Income/Loss From Continuing Operations Before Tax
54.21%
-41.76
-27.08 -23.01 -30.44 -33.12
Income Tax Expense/Benefit
0.117
- 0.007 - -
Income/Loss From Continuing Operations After Tax
54.64%
-41.88
-27.08 -23.02 -30.44 -33.12
Net Income/Loss
54.64%
-41.88
-27.08 -23.02 -30.44 -33.12
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
31.05%
134.48
102.62 0.8075 96.20 96.17
Diluted Average Shares
31.05%
134.48
102.62 0.8075 96.20 96.17
Basic Earnings Per Share
19.23%
-0.31
-0.26 -0.22 -0.32 -0.34
Diluted Earnings Per Share
19.23%
-0.31
-0.26 -0.22 -0.32 -0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.36
price down icon 0.93%
$83.10
price down icon 3.56%
$27.82
price down icon 2.76%
$96.74
price down icon 7.26%
$145.93
price up icon 0.10%
biotechnology ONC
$324.34
price down icon 3.38%
Capitalizzazione:     |  Volume (24 ore):